Want to be on the cutting edge of disease treatment? Learn how companies like Immunyx Pharma are on the front lines in the battle against unknown diseases with the JLABS/BARDA Blue Knight program. Seth Salpeter, Co-Founder and CEO of Immunyx Pharma guests on BioTalk with Rich Bendis
Stu Solomon, Connected DMV (EP.74)
Dr. Carol Nacy, Sequella (EP.73)
Praduman “PJ” Jain, Vibrent Health (EP.72)
Scott Carmer, NexImmune (EP.71)
Marc Elrich, Montgomery County Executive (EP.70)
Justin Yang, BARDA (EP.69)
Benjamin Wu, Montgomery County Economic Development Corporation (MCEDC) (EP.68)
Jeff Galvin, American Gene Technologies (AGT) (EP.67)
John Trizzino, Novavax (EP.66)
Sally Mossman, GSK (EP.65)
Crab Trap Winners
Sally Allain, MSc., MBA , Head, JLABS @ Washington, DC (EP.63)
Michele L. Whelley, Economic Alliance of Greater Baltimore (EAGB) (EP.62)
Lisa Johnson, BioForward Wisconsin (EP.61)
Jennifer Butler, Innate Pharma US Inc. (EP.60)
Darryl Sampey, BioFactura (EP.59)
Alex Philippidis, Genetic Engineering and Biotechnology News (EP.58)
Charles Andres, Ph.D, RAC, and Christian Barrow (EP.57)
Anthony D. Saleh, Ph.D., miRecule (EP.56)
Dr. Faz Bashi, M.D. and Angel investor (EP.55)
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money